Coverage
-
March 18, 2016
When Amarin Pharma this month nailed down a seismic win for Big Pharma's off-label marketing, it was the climax of a First Amendment case painstakingly developed by three seasoned attorneys at Cahill Gordon & Reindel LLP. In an interview with Law360, they discussed the case's origins, why it succeeded and where things go from here.
15 other articles on this case.
View all »